Complete Filing Data
ACTUATE THERAPEUTICS, INC. reported Stockholders Equity of $7.92 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ACTUATE THERAPEUTICS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | -$22.2M | -$27.3M | -$24.7M |
| Research And Development Expense | $10.3M | $18.7M | $21.7M |
| Operating Income Loss | -$22.5M | -$25.2M | -$25.0M |
| Operating Expenses | $22.5M | $25.2M | $25.0M |
| Nonoperating Income Expense | $267.5K | -$2.1M | $229.2K |
| Interest Expense Nonoperating | $20.3K | $18.7K | $43.6K |
| General And Administrative Expense | $12.2M | $6.5M | $3.3M |
| Income Taxes Paid Net | $800.00 | $800.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$5.4M | -$5.9M | -$6.3M | -$6.0M | -$6.6M | -$8.3M | -$6.3M | -$5.5M | -$5.3M |
| Research And Development Expense | $2.2M | $2.8M | $3.2M | $3.8M | $4.4M | $6.9M | $5.8M | $4.8M | |
| Operating Income Loss | -$5.5M | -$6.0M | -$6.4M | -$5.4M | -$5.4M | -$7.8M | -$6.5M | -$5.6M | |
| Operating Expenses | $5.5M | $6.0M | $6.4M | $5.4M | $5.4M | $7.8M | $6.5M | $5.6M | |
| Nonoperating Income Expense | $64.9K | $19.5K | $48.6K | -$578.1K | -$1.1M | -$522.8K | $137.7K | $60.1K | |
| Interest Expense Nonoperating | $5.1K | $5.1K | $5.1K | $3.5K | $5.1K | $5.1K | $5.1K | $5.1K | |
| General And Administrative Expense | $3.3M | $3.2M | $3.1M | $1.6M | $1.1M | $912.8K | $714.2K | $807.2K | |
| Income Taxes Paid Net | $800.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $7.9M | $104.2K | -$99.6M | -$75.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $13.2M | $8.6M | $3.0M | $20.4M |
| Loss On Issuance Of Related Party Convertible Notes Payable At Fair Value | $0.00 | $400.0K | $0.00 | |
| Change In Estimated Fair Value Of Related Party Convertible Notes Payable | $0.00 | $2.2M | $0.00 | |
| Retained Earnings Accumulated Deficit | -$154.6M | -$132.4M | -$105.1M | |
| Prepaid Expense And Other Assets Current | $484.0K | $566.3K | $36.9K | |
| Other Accrued Liabilities Current | $3.6M | $5.9M | $3.2M | |
| Loss On Issuance Of Related Party Convertible Note Payable At Fair Value | $0.00 | $400.0K | $0.00 | |
| Liabilities Noncurrent | $405.0K | $411.8K | $1.5M | |
| Liabilities Current | $5.7M | $8.8M | $6.9M | |
| Liabilities And Stockholders Equity | $14.0M | $9.3M | $3.0M | |
| Liabilities | $6.1M | $9.2M | $8.4M | |
| Interest Payable Current | $27.0K | $71.0K | $0.00 | |
| Common Stock Value | $23.00 | $20.00 | $2.00 | |
| Change In Estimated Fair Value Of Related Party Convertible Note Payable | $0.00 | $2.2M | $0.00 | |
| Cash Equivalents At Carrying Value | $13.2M | $8.6M | $3.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $4.5M | $5.7M | -$17.5M | |
| Assets Current | $13.6M | $9.2M | $3.0M | |
| Assets | $14.0M | $9.3M | $3.0M | |
| Accrued Bonuses Current | $588.3K | $888.4K | $277.5K | |
| Accounts Payable Current | $1.5M | $1.9M | $3.4M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | |
| Other Assets Noncurrent | $392.5K | $110.5K | $0.00 | |
| Deferred Offering Costs Unpaid And Accrued | $115.5K | $0.00 | ||
| Repayments Of Short Term Debt | $0.00 | $200.0K | $0.00 | |
| Reclassification Of Warrant Liability To Equity Upon Exchange Of Not Inthemoney Series B And Series C Redeemable Convertible Preferred Stock Warrants For Warrants To Purchase Common Stock | $0.00 | $485.2K | $0.00 | |
| Interest Payable Current And Noncurrent | $130.0K | |||
| Gain On Settlement Of Warrant Liability | $0.00 | $343.2K | $0.00 | |
| Conversion Of Related Party Convertible Notes Payable Into Common Stock Upon Initial Public Offering | $0.00 | $8.1M | $0.00 | |
| Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Upon Initial Public Offering | $0.00 | $94.2M | $0.00 | |
| Accounts Payable Other Current And Noncurrent | $405.0K | |||
| Temporary Equity Liquidation Preference | $0.00 | $121.0M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $94.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $10.9M | -$2.7M | -$5.1M | $5.4M | -$114.3M | -$107.8M | -$92.1M | -$86.0M | -$80.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.9M | $6.5M | $3.9M | $13.5M | $351.7K | $2.1M | $8.5M | $14.1M | ||
| Loss On Issuance Of Related Party Convertible Notes Payable At Fair Value | $0.00 | $0.00 | $0.00 | $0.00 | $200.0K | $200.0K | $0.00 | $0.00 | ||
| Change In Estimated Fair Value Of Related Party Convertible Notes Payable | $0.00 | $0.00 | $0.00 | $1.2M | $700.0K | $300.0K | $0.00 | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$150.1M | -$144.6M | -$138.7M | -$125.9M | -$120.0M | |||||
| Prepaid Expense And Other Assets Current | $519.2K | $195.9K | $359.2K | $739.3K | $198.0K | |||||
| Other Accrued Liabilities Current | $4.3M | $4.6M | $5.2M | $6.1M | $6.9M | |||||
| Loss On Issuance Of Related Party Convertible Note Payable At Fair Value | $0.00 | $200.0K | ||||||||
| Liabilities Noncurrent | $405.0K | $421.9K | $416.8K | $406.7K | $1.7M | |||||
| Liabilities Current | $6.4M | $9.2M | $9.2M | $8.5M | $20.1M | |||||
| Liabilities And Stockholders Equity | $17.7M | $7.0M | $4.5M | $14.3M | $1.7M | |||||
| Liabilities | $6.8M | $9.6M | $9.6M | $8.9M | $21.8M | |||||
| Interest Payable Current | $22.0K | $71.0K | $71.0K | $71.0K | $70.1K | |||||
| Common Stock Value | $23.00 | $20.00 | $20.00 | $20.00 | $2.00 | |||||
| Change In Estimated Fair Value Of Related Party Convertible Note Payable | $0.00 | $300.0K | ||||||||
| Cash Equivalents At Carrying Value | $16.9M | $6.5M | $3.9M | $13.5M | $351.7K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$4.8M | -$890.4K | ||||||||
| Assets Current | $17.4M | $6.7M | $4.2M | $14.3M | $549.7K | |||||
| Assets | $17.7M | $7.0M | $4.5M | $14.3M | $1.7M | |||||
| Accrued Bonuses Current | $846.3K | $1.4M | $1.2M | $0.00 | $277.5K | |||||
| Accounts Payable Current | $1.2M | $3.2M | $2.6M | $2.3M | $5.9M | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Other Assets Noncurrent | $269.9K | $280.3K | $234.5K | |||||||
| Deferred Offering Costs Unpaid And Accrued | $101.0K | $367.7K | ||||||||
| Repayments Of Short Term Debt | ||||||||||
| Reclassification Of Warrant Liability To Equity Upon Exchange Of Not Inthemoney Series B And Series C Redeemable Convertible Preferred Stock Warrants For Warrants To Purchase Common Stock | ||||||||||
| Interest Payable Current And Noncurrent | $11.8K | $6.8K | $1.7K | $70.1K | ||||||
| Gain On Settlement Of Warrant Liability | ||||||||||
| Conversion Of Related Party Convertible Notes Payable Into Common Stock Upon Initial Public Offering | ||||||||||
| Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Upon Initial Public Offering | ||||||||||
| Accounts Payable Other Current And Noncurrent | $405.0K | $405.0K | $405.0K | $405.0K | ||||||
| Temporary Equity Liquidation Preference | $0.00 | $124.9M | ||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $94.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Payments Of Stock Issuance Costs | $302.8K | $0.00 | $321.5K |
| Share Based Compensation | $6.0M | $2.0M | $423.5K |
| Proceeds From Convertible Debt | $0.00 | $5.5M | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$19.2M | -$21.8M | -$21.6M |
| Net Cash Provided By Used In Financing Activities | $23.7M | $27.5M | $4.1M |
| Increase Decrease In Other Current Assets | -$82.3K | $529.4K | $3.2K |
| Increase Decrease In Other Accrued Liabilities | -$2.4M | $2.7M | $1.1M |
| Increase Decrease In Interest Payable Net | -$71.0K | -$71.0K | $0.00 |
| Increase Decrease In Employee Related Liabilities | -$300.1K | $610.9K | $145.5K |
| Increase Decrease In Accounts Payable | -$512.5K | -$1.5M | $1.3M |
| Increase Decrease In Other Noncurrent Assets | -$110.5K | $110.5K | $0.00 |
| Proceeds From Short Term Debt | $0.00 | $200.0K | $0.00 |
| Proceeds From Issuance Initial Public Offering | $0.00 | $24.0M | $0.00 |
| Payments For Repurchase Of Initial Public Offering | $0.00 | $1.9M | $0.00 |
| Proceeds From Stock Options Exercised | $34.1K | $0.00 | |
| Proceeds From Issuance Of Private Placement | $4.6M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q1 2024 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|
| Payments Of Stock Issuance Costs | $133.5K | $3.7M | $142.8K | $114.7K | $206.8K |
| Share Based Compensation | $1.1M | $148.2K | |||
| Proceeds From Convertible Debt | $0.00 | $4.5M | |||
| Net Cash Provided By Used In Operating Activities | -$4.6M | -$5.2M | |||
| Net Cash Provided By Used In Financing Activities | -$133.5K | $4.4M | |||
| Increase Decrease In Other Current Assets | -$207.1K | $82.9K | |||
| Increase Decrease In Other Accrued Liabilities | -$721.1K | $2.0M | |||
| Increase Decrease In Interest Payable Net | $5.1K | $5.1K | |||
| Increase Decrease In Employee Related Liabilities | $349.4K | $0.00 | |||
| Increase Decrease In Accounts Payable | $622.2K | $483.7K | |||
| Increase Decrease In Other Noncurrent Assets | -$110.5K | $0.00 | |||
| Proceeds From Short Term Debt | |||||
| Proceeds From Issuance Initial Public Offering | |||||
| Payments For Repurchase Of Initial Public Offering | |||||
| Proceeds From Stock Options Exercised | |||||
| Proceeds From Issuance Of Private Placement |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 21.0M | 8.4M | 1.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 21.0M | 8.4M | 1.4M |
| Earnings Per Share Diluted | $-1.06 | $-3.26 | $-17.24 |
| Earnings Per Share Basic | $-1.06 | $-3.26 | $-17.24 |
| Common Stock Shares Outstanding | 23.2M | 19.5M | 1.7M |
| Common Stock Shares Issued | 23.2M | 19.5M | 1.7M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 38.1M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Temporary Equity Shares Outstanding | 0.00 | 24.7M | |
| Temporary Equity Shares Issued | 0.00 | 24.7M | |
| Temporary Equity Shares Authorized | 0.00 | 33.5M | |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 21.4M | 19.6M | 19.5M | 10.8M | 1.6M | 1.5M | 1.5M | 1.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 21.4M | 19.6M | 19.5M | 10.8M | 1.6M | 1.5M | 1.5M | 1.4M |
| Earnings Per Share Diluted | $-0.25 | $-0.30 | $-0.32 | $-0.55 | $-4.20 | $-5.40 | $-4.31 | $-3.88 |
| Earnings Per Share Basic | $-0.25 | $-0.30 | $-0.32 | $-0.55 | $-4.20 | $-5.40 | $-4.31 | $-3.88 |
| Common Stock Shares Outstanding | 23.2M | 20.5M | 19.5M | 19.5M | 1.7M | |||
| Common Stock Shares Issued | 23.2M | 20.5M | 19.5M | 19.5M | 1.7M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 38.1M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Temporary Equity Shares Outstanding | 0.00 | 24.7M | ||||||
| Temporary Equity Shares Issued | 0.00 | 24.7M | ||||||
| Temporary Equity Shares Authorized | 0.00 | 33.5M | ||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.0M | $2.0M | $423.5K |
| Fair Value Adjustment Of Warrants | $0.00 | $78.9K | $79.8K |
| Investment Income Interest | $287.7K | $222.3K | $352.7K |
| Interest Paid Net | $71.0K | $71.0K | $0.00 |
| Additional Paid In Capital | $162.5M | $132.5M | $5.5M |
| Gain On Settlement Of Warrants | $0.00 | $343.2K | $0.00 |
| Stock Issued During Period Value New Issues | $4.6M | $22.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.8M | $1.6M | $1.1M | $566.0K | $90.0K | $148.2K | $155.2K | $73.1K | $73.1K |
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $0.00 | -$194.0K | $240.3K | $32.5K | -$16.9K | $50.2K | |
| Investment Income Interest | $70.0K | $24.5K | $53.6K | $80.7K | $8.6K | $14.8K | $125.9K | ||
| Interest Paid Net | $0.00 | $0.00 | |||||||
| Additional Paid In Capital | $161.0M | $142.0M | $133.6M | $131.3M | $5.7M | ||||
| Gain On Settlement Of Warrants | $0.00 | $343.2K | $0.00 | ||||||
| Stock Issued During Period Value New Issues | -$29.1K | $4.6M | $22.0M | $0.00 |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.